EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycemic Variability as a Predictor of Mortality in Sepsis Patients With Concurrent Persistent Inflammation, Immunosuppression, and Catabolism Syndrome

Glykämische Variabilität als Prädiktor der Mortalität bei Sepsispatient:innen mit persistierender Inflammation, Immunsuppression und Katabolismus-Syndrom

Shuhang Wang iD, Li Liu iD, Bowen Li, Yancun Liu, Yanfen Chai

Immunity, Inflammation and Disease · 2026-03 · 14 (3)

DOI: 10.1002/iid3.70400 ↗

Auf einen Blick

Bei 1.353 kritisch kranken Sepsispatient:innen war eine höhere GVC mit höherer 28-Tage- und 180-Tage-Mortalität verbunden. Die höchste GVC-Tertile zeigte ein erhöhtes 28-Tage-Mortalitätsrisiko.

Fragestellung

Besteht bei Sepsispatient:innen mit PICS ein Zusammenhang zwischen GVC und Mortalität?

Methode

Analyse von MIMIC-IV-Daten zu 1.353 Sepsispatient:innen; Cox-Regression und Kaplan–Meier-Analyse; Modellierung mit Boruta sowie ML- und DL-Algorithmen; externe Validierung in 116 Patient:innen.

Ergebnisse

Die höchste GVC-Tertile war mit höherer 28-Tage-Mortalität assoziiert: OR 1,60 (95 %-KI 1,11–2,32). Das TabPFN-Modell zur 28-Tage-Mortalität erreichte eine AUC von 0,960.

Schlussfolgerung der Autor:innen

GVC zeigte signifikante Zusammenhänge mit 28-Tage- und 180-Tage-Mortalität bei Sepsispatient:innen mit PICS. DL-Modelle bestätigten GVC als robusten Prädiktor.

Kernaussagen

  • Höhere GVC war mit höherer Mortalität assoziiert.
  • Höchste GVC-Tertile: OR 1,60 (95 %-KI 1,11–2,32).
  • TabPFN-Modell: AUC 0,960 für 28-Tage-Mortalität.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 06.03.2026. Verfasst von Shuhang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Sepsis, Inflammation, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, Tianjin Key Medical Discipline (Specialty) Construction Project.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis is a life‐threatening condition caused by infection, which triggers dysregulated systemic inflammatory responses. Among sepsis patients, those who concurrently develop persistent inflammation, immunosuppression, and catabolism syndrome (PICS) have a significantly poorer prognosis. It has been demonstrated that associations exist between elevated glycemic variation coefficient (GVC) levels and the development of PICS in septic populations. However, the association between GVC and adverse clinical outcomes in the subgroup of septic patients with PICS requires further investigation.

Methods

The study analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC‐IV) database, which comprised 1353 critically ill septic patients who developed nosocomial infections during hospitalization. Based on the 2024 Critical Care Medicine Guidelines on Glycemic Control, the patients included in this study will be divided into GVC < 20 group, 20 ≤ GVC ≤ 36 group, and GVC > 36 group. The primary outcome measure was 28‐day all‐cause mortality, with secondary outcomes comprising in‐hospital mortality and 180‐day mortality. Cox proportional hazards regression and Kaplan–Meier analysis were utilized to examine the relationship between GVC and adverse outcomes. The Boruta algorithm evaluated the predictive capacity of GVC, followed by the development of prognostic models through machine learning (ML) and deep learning (DL) algorithms, externally validated using an independent cohort of 116 patients from the Emergency Department of Tianjin Medical University General Hospital.

Results

The analysis included 1353 septic patients. Kaplan–Meier analysis indicates that the highest GVC tertile has significant differences in 28‐day and 180‐day mortality rates. Cox regression analysis revealed that patients in the highest GVC tertile had a significantly elevated 28‐day mortality risk. (OR = 1.60, 95% CI: 1.11–2.32, p < 0.05). The Boruta algorithm identified GVC as a key predictor for mortality risk. The 28‐day mortality prediction model developed using tabular prior‐data fitted network (TabPFN) achieved an area under the curve (AUC) of 0.960.

Conclusion

GVC demonstrated significant correlations with 28‐day and 180‐day mortality in sepsis patients complicated by PICS. DL models confirm the utility of GVC as a robust prediction tool for septic patients, providing valuable references for clinical decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisInflammationBlood GlucoseHumansFemaleMalePrognosisMiddle AgedHospital MortalityAgedMachine LearningCritical Illness

Stichwörter der Autor:innen

Boruta algorithmglucose variability coefficientmachine learningpersistent inflammation, immunosuppression, and catabolism syndromesepsis

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Tianjin Medical University General Hospital, Tianjin, China.
  • College of Environmental Science and Engineering, Nankai University, Tianjin, China.

ORCID-Profile: Shuhang Wang, Li Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin
  • Tianjin Key Medical Discipline (Specialty) Construction Project
  • Natural Science Foundation of Tianjin City

Zitieren

APA

Wang, S., Liu, L., Li, B., Liu, Y., & Chai, Y. (2026). Glycemic Variability as a Predictor of Mortality in Sepsis Patients With Concurrent Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70400

Vancouver

Wang S, Liu L, Li B, Liu Y, Chai Y. Glycemic Variability as a Predictor of Mortality in Sepsis Patients With Concurrent Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70400

BibTeX
@article{Wang2026,
  author = {Wang, Shuhang and Liu, Li and Li, Bowen and Liu, Yancun and Chai, Yanfen},
  title = {Glycemic Variability as a Predictor of Mortality in Sepsis Patients With Concurrent Persistent Inflammation, Immunosuppression, and Catabolism Syndrome},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/iid3.70400}
}
Kostenlos starten →